Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Revenue (2016 - 2025)

Apyx Medical (APYX) has disclosed Revenue for 15 consecutive years, with $19.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Revenue rose 34.75% year-over-year to $19.2 million, compared with a TTM value of $52.8 million through Dec 2025, up 9.86%, and an annual FY2025 reading of $52.8 million, up 9.86% over the prior year.
  • Revenue was $19.2 million for Q4 2025 at Apyx Medical, up from $12.9 million in the prior quarter.
  • Across five years, Revenue topped out at $19.2 million in Q4 2025 and bottomed at $8.6 million in Q1 2021.
  • Average Revenue over 5 years is $12.3 million, with a median of $12.1 million recorded in 2023.
  • The sharpest move saw Revenue soared 161.27% in 2021, then fell 25.04% in 2022.
  • Year by year, Revenue stood at $16.8 million in 2021, then fell by 25.04% to $12.6 million in 2022, then grew by 16.26% to $14.7 million in 2023, then dropped by 3.0% to $14.2 million in 2024, then surged by 34.75% to $19.2 million in 2025.
  • Business Quant data shows Revenue for APYX at $19.2 million in Q4 2025, $12.9 million in Q3 2025, and $11.4 million in Q2 2025.